Literature DB >> 8014296

C1 esterase inhibitor (C1-INH) can reduce plasma concentrations of the complement activation product C5a.

W Nürnberger, K Petrik, S Burdach, U Göbel.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 8014296     DOI： 10.1007/bf01704710

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  6 in total

1.  C1-inhibitor concentrate for sepsis-related capillary leak syndrome.

Authors:  W Nürnberger; U Göbel; H Stannigel; B Eisele; A Janssen; U Delvos
Journal:  Lancet       Date:  1992-04-18       Impact factor: 79.321

2.  In vivo induction of gamma interferon and tumor necrosis factor by interleukin-2 infusion following intensive chemotherapy or autologous marrow transplantation.

Authors:  H E Heslop; D J Gottlieb; A C Bianchi; A Meager; H G Prentice; A B Mehta; A V Hoffbrand; M K Brenner
Journal:  Blood       Date:  1989-09       Impact factor: 22.113

3.  [Immune stimulation with interleukin-2 after autologous stem cell transplantation in children and adolescents with solid tumors].

Authors:  H J Laws; D Dilloo; H Hanenberg; D Schwamborn; S Burdach; U Göbel
Journal:  Klin Padiatr       Date:  1993 Jul-Aug       Impact factor: 1.349

4.  Activity of C1 esterase inhibitor in patients with vascular leak syndrome after bone marrow transplantation.

Authors:  W Nürnberger; I Michelmann; K Petrik; S Holthausen; R Willers; G Lauermann; B Eisele; U Delvos; S Burdach; U Göbel
Journal:  Ann Hematol       Date:  1993-07       Impact factor: 3.673

Review 5.  C1-inhibitor substitution therapy in septic shock and in the vascular leak syndrome induced by high doses of interleukin-2.

Authors:  C E Hack; A C Ogilvie; B Eisele; A J Eerenberg; J Wagstaff; L G Thijs
Journal:  Intensive Care Med       Date:  1993       Impact factor: 17.440

6.  Complement activation in cancer patients undergoing immunotherapy with interleukin-2 (IL-2): binding of complement and C-reactive protein by IL-2-activated lymphocytes.

Authors:  G Vachino; J A Gelfand; M B Atkins; J D Tamerius; P Demchak; J W Mier
Journal:  Blood       Date:  1991-11-15       Impact factor: 22.113
  6 in total
  2 in total

1.  Complement inhibition attenuates acute kidney injury after ischemia-reperfusion and limits progression to renal fibrosis in mice.

Authors:  Juan S Danobeitia; Martynas Ziemelis; Xiaobo Ma; Laura J Zitur; Tiffany Zens; Peter J Chlebeck; Edwin S Van Amersfoort; Luis A Fernandez
Journal:  PLoS One       Date:  2017-08-23       Impact factor: 3.240

Review 2.  Crosstalk between the renin-angiotensin, complement and kallikrein-kinin systems in inflammation.

Authors:  Zivile Bekassy; Ingrid Lopatko Fagerström; Michael Bader; Diana Karpman
Journal:  Nat Rev Immunol       Date:  2021-11-10       Impact factor: 108.555
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.